Skip to main content

GlaxoSmithKline’s Rockville chief lays out priorities for 2018 – Washington Business Journal

By December 11, 2017News
rip-ballou-gsk-image

rip-ballou-gsk-image

British pharmaceutical giant GlaxoSmithKline PLC said it finally has a full team in place at its vaccine hub in Rockville and is ready to take on some of the region’s most well-known biotech competitors with part of its product lineup.

{iframe}https://www.bizjournals.com/washington/news/2017/12/07/glaxosmithklines-rockville-chief-lays-out.html{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.